NCT00006098
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +46 more
- Locations
-
- Memorial Sloan-Kettering Cancer Center New York, United States
Clinical trial condition
Burkitt Lymphoma
Explore clinical trials studying Burkitt Lymphoma. Study availability and eligibility vary by location and protocol.
695 public trials
115 recruiting studies
Burkitt Lymphoma trial results
NCT00010192
- Conditions
- B-cell Adult Acute Lymphoblastic Leukemia, Burkitt Lymphoma, Chronic Disease, +82 more
- Locations
-
- Ohio State University Medical Center Columbus, Ohio, United States
Completed
Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas
NCT00101270
- Conditions
- Astrocytoma, Burkitt Lymphoma, Childhood Burkitt Lymphoma, +115 more
- Locations
-
- COG Phase I Consortium Arcadia, California, United States
NCT00042900
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +90 more
- Locations
-
- Memorial Sloan-Kettering Cancer Center New York, United States
NCT00005613
- Conditions
- Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +29 more
- Locations
-
- Florida Cancer Specialists Fort Myers, Florida, United States
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
NCT00006373
- Conditions
- Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +29 more
- Locations
-
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
NCT00109824
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +19 more
- Locations
-
- Ohio State University Medical Center Columbus, Ohio, United States
NCT00659568
- Conditions
- Adenocarcinoma, Blood Protein Disorders, Breast Cancer, +84 more
- Locations
-
- London Regional Cancer Program at London Health Sciences Centre London, Ontario, Canada
NCT00073944
- Conditions
- Adenocarcinoma, Adenocarcinoma Of Esophagus, Adnexal Diseases, +140 more
- Locations
-
- Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States
Completed
Study of the Safety and Tolerability of PCI-32765 in Patients With Recurrent B Cell Lymphoma
NCT00849654
- Conditions
- B-cell Leukemia, B-cell Lymphoma, Blood Protein Disorders, +31 more
- Locations
-
- Stanford University School of Medicine Palo Alto, California, United States
- University of Chicago Chicago, Illinois, United States
- National Cancer Institute Bethesda, Maryland, United States
- New York Prebyterian Hospital Cornell Medical Center New York, United States